Investors

View Stock Information
Corporate presentation image
Corporate Presentation (PDF)

Corporate Profile

Sernova is a regenerative medicine company developing therapeutic technologies with multibillion-dollar market potential for each of its clinical indications.

Press Releases

February 3, 2025
Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
January 30, 2025
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 13, 2025
Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders
View All Press Releases

Events

January 10, 2025
Annual General and Special Meeting of Shareholders
December 13, 2024 ET
Sernova Virtual Investor Event: Meet Our Leadership
View All Events

IR Contact


David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Scroll to Top